(Q37797798)

English

Efficacy and tolerability of olmesartan/amlodipine combination therapy in patients with mild-to-severe hypertension: focus on 24-h blood pressure control.

scientific article published on October 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20921092%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Efficacy and tolerability of olmesartan/amlodipine combination therapy in patients with mild-to-severe hypertension: focus on 24-h blood pressure control (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20921092%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

arterial hypertension

0 references

Gianfranco Parati

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20921092%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20921092%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Satoshi Hoshide

4

object named as

Satoshi Hoshide

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20921092%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Juan Eugenio Ochoa

2

object named as

Juan Eugenio Ochoa

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20921092%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

5

object named as

Laura Lonati

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20921092%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Carlos Ramos

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20921092%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

1 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20921092%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Therapeutic advances in cardiovascular disease

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20921092%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20921092%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20921092%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

301-313

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20921092%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting Mortality

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Night time blood pressure variability is a strong predictor for cardiovascular events in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Selected major risk factors and global and regional burden of disease

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Circadian rhythm of blood pressure and the relation to cardiovascular events

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Blood pressure surge on rising

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study.

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Global burden of blood-pressure-related disease, 2001.

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Ambulatory blood pressure monitoring use in hypertension research and clinical practice.

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

The use of a single-pill calcium channel blocker/statin combination in the management of hypertension and dyslipidemia: a randomized, placebo-controlled, multicenter study

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Subgroup analyses of an efficacy and safety study of concomitant administration of amlodipine besylate and olmesartan medoxomil: evaluation by baseline hypertension stage and prior antihypertensive medication use.

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Combination therapy in the management of hypertension: focus on angiotensin receptor blockers combined with diuretics

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Why Is Out-of-Office Blood Pressure Measurement Needed?

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Do we need out-of-office blood pressure in every patient?

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Ambulatory blood-pressure monitoring

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Prognostic value of different indices of blood pressure variability in hypertensive patients.

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Fixed-drug combinations as first-line treatment for hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Determinants of blood pressure variability in youth: at the roots of hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Predicting Cardiovascular Risk Using Conventional vs Ambulatory Blood Pressure in Older Patients With Systolic Hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Olmesartan compared with other angiotensin II receptor antagonists: head-to-head trials

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study.

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States.

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Prognostic significance of blood pressure variability after thrombolysis in acute stroke

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Prognostic value of 24-hour blood pressure variability

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

EFFECTS OF BLOOD-PRESSURE MEASUREMENT BY THE DOCTOR ON PATIENT'S BLOOD PRESSURE AND HEART RATE

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Clinical Relevance of Day-by-Day Blood Pressure and Heart Rate Variability

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Home blood pressure telemonitoring improves hypertension control in general practice. The TeleBPCare study

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

The smoothness index

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Home blood-pressure monitoring: US and European consensus

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Prognostic Relevance of Blood Pressure Variability

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Awake Systolic Blood Pressure Variability Correlates With Target-Organ Damage in Hypertensive Subjects

1 reference

https://api.crossref.org/works/10.1177%2F1753944710380228

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37797798&oldid=1744751750"